2014
DOI: 10.1007/s11255-014-0761-7
|View full text |Cite
|
Sign up to set email alerts
|

Does the KDIGO CKD risk stratification based on GFR and proteinuria predict kidney graft failure?

Abstract: Risk group stratification according to KDIGO guideline on CKD may prove useful in predicting graft outcome, but this should be confirmed in larger cohorts.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
7
0
6

Year Published

2015
2015
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(14 citation statements)
references
References 39 publications
1
7
0
6
Order By: Relevance
“…2 As such, proteinuria has been included in risk stratification for patients with chronic kidney disease (CKD) in the general population 3 and the utility of this stratification has been assessed in renal transplant recipients. 4 Proteinuria is commonly present after transplantation. Because it is often a marker of allograft damage and is a potentially modifiable risk factor, it is important to recognize early.…”
mentioning
confidence: 99%
“…2 As such, proteinuria has been included in risk stratification for patients with chronic kidney disease (CKD) in the general population 3 and the utility of this stratification has been assessed in renal transplant recipients. 4 Proteinuria is commonly present after transplantation. Because it is often a marker of allograft damage and is a potentially modifiable risk factor, it is important to recognize early.…”
mentioning
confidence: 99%
“…21,27 These however are very cumbersome and were developed using data from one year post transplant which limit their clinical utility. 21,27 Bucsa et al 28 examined the association between GFR categories, proteinuria, and outcomes in 231 renal transplant recipients but used 24-hour urine total protein collections which were then converted to estimated albumin excretion and the 4 variable MDRD equation. The composite outcome studied was death, ESRD, or a greater than 30% decline in eGFR from 6 months posttransplant.…”
Section: Discussionmentioning
confidence: 99%
“…Хроническая болезнь почек (ХБП) -серьезная проблема для здравоохранения, что нашло отражение в увеличении числа публикаций о ХБП в последние годы, особенно после выхода в свет регламентирующих рекомендаций по ХБП в 2002 и 2012 гг. [1,2]. Проблема ХПБ состоит, прежде всего, в том, что, как многие хронические неинфекционные заболевания, болезнь долгое время протекает бессимптомно, а при позднем выявлении быстро развивается почечная недостаточность c исходом в терминальную стадию и смерть.…”
Section: Gfr and Cardiovascular Risk скф и сердечно-сосудистый рискunclassified